Nonclinical safety evaluation of two vaccine candidates for herpes simplex virus type 2 to support combined administration in humans
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Applied Toxicology"
DOI: 10.1002/jat.4404
Abstract: Herpes simplex virus type 2 (HSV‐2) is the most common cause of genital disease worldwide. The development of an effective HSV‐2 vaccine would significantly impact global health based on the psychological distress caused by genital… read more here.
Keywords: simplex virus; nonclinical safety; virus type; two vaccine ... See more keywords